Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
488.24-2.19 (-0.45%)
As of 11:19AM EDT. Market open.
Loading interactive chart…
- Editor's pickYahoo Finance Video
Vaccine trials on pregnant women show reassuring results: Doctor
Dr. Kathleen Jordan, SVP of Medical Affairs at Tia, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus.
- PR Newswire
New Dupixent® (dupilumab) Analyses at Two Upcoming Dermatology Congresses Reinforce Long-term Safety and Efficacy Profile in Patients with Atopic Dermatitis as Young as 6 Years
Nearly 30 data presentations at AAD and ESPD highlight the impact of Dupixent on disease measures including rapid itch relief and sustained improvement in disease severity, as well as quality of life in clinical and real-world settings
- Zacks
Why Regeneron (REGN) Could Beat Earnings Estimates Again
Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
© 2021 Verizon Media. All rights reserved.
